Swiss Startups

Addressing major challenges in antimicrobial therapies.

First-in-class plant-derived active vitamin D for CKD

Developing the next generation of cell-based therapies.

Next-generation liquid biopsy solutions.

A new generation of targeted drugs for cancer and beyond.

Off-the-shelf stem cell therapy for wound and skin repair

Next-gen anticoagulant with a built-in antidote for reversal

The world’s fastest bacterial contamination detection tool.

Development of sublingual delivery of peptides and proteins for chronic diseases

Analysis of genetic variation from next-generation sequencing data

Automated Microbial Monitoring

A new class of immunotherapies based on nanoparticles.